Adicon Holdings Limited

9860

KYG0086A1076

Healthcare Facilities & Services

Market Closed - Hong Kong S.E. Other stock markets 01:38:30 12/09/2024 pm IST			5-day change	1st Jan Change
7.700 ^HKD	-0.65%		-17.12%	-40.95%

30/08	Adicon Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2024	CI
29/06	281,541,805 Ordinary Shares of Adicon Holdings Limited are subject to a Lock-Up Agreement Ending on 29-JUN-2024.	CI

This article is reserved for members

To unlock the article, REGISTER!

100% Free Registration

Already a customer? Log In

Latest news about Adicon Holdings Limited

Adicon Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2024	30/08	CI
281,541,805 Ordinary Shares of Adicon Holdings Limited are subject to a Lock-Up Agreement Ending on 29-JUN-2024.	29/06	CI
Adicon Holdings Limited commences an Equity Buyback for 72,735,479 shares, representing 10% of its issued share capital, under the authorization approved on May 30, 2024.	10/06	CI
ADICON Holdings to Repurchase 5% of Shares	05/06	MT
Adicon Holdings Limited Approves Appointment of Mr. Zhou Mintao as A Non-Executive Director	30/05	CI
ADICON Holdings' 2023 Profit, Revenue Decline	29/04	MT
Adicon Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	28/03	CI
169,974,982 Ordinary Shares of Adicon Holdings Limited are subject to a Lock-Up Agreement Ending on 29-DEC-2023.	29/12	CI
ADICON Holdings' Q3 Revenue Falls; Shares Rise 3%	30/23/30	MT
Adicon Holdings Limited Provides Unaudited Consolidated Revenue Guidance for the Three Months Ended September 30, 2023	29/23/29	CI
ADICON's H1 Profit Down as Revenue Slumps 33%	23/23/23	MT
Hong Kong Stocks End Up Flat Over Weak China Factory Data; ADICON Closes 12% Higher at Debut	30/23/30	MT
ADICON Holdings Opens Flat in Hong Kong Trading Debut	30/23/30	MT
ADICON Holdings Raises HK$83.9 Million in Hong Kong IPO	29/23/29	MT
Adicon Holdings Limited has completed an IPO in the amount of HKD 408.9316 million.	28/23/28	CI

Adicon Holdings Ltd is an investment holding company principally engaged in the provision of independent clinical laboratory (ICL) services. The Company primarily provides testing services to hospitals, medical institutions, medical examination centers, consumers, pharmaceutical companies and contract research organizations (CROs). The Company's inspection services mainly include routine tests, esoteric tests, clinical immunologic testing, clinical chemistry testing, clinical molecular biology testing, pathology testing and others testing. The Company is also engaged in the sales of medical testing equipment. The Company principally conducts its businesses in the domestic market.

Employees

6,083

Sector

Healthcare Facilities & Services

More about the company